Stocks-RPRX-Royalty Pharma PLC

RPRX Royalty Pharma PLC

43.01 -0.84 (-1.92%)
Invest
Invest

Overview

Prev Close43.01
Day's Range 42.52 - 43.50
52 Week Range 36.12 - 44.61
Average Volume (3m)1.67M
1-Year Return13.31%
Beta0.8564
Market Cap18.97B
P/E Ratio37.06
Revenue2.25B
EPS1.1604
Dividend (Yield) (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.723/06/202206/09/202215/11/202239.0040.0041.0042.0043.0044.0045.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Pablo Gerardo Legorreta
Employees 66

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Royalty Pharma PLC's revenues increased by 7.85% and amounted to 2.29B. Net income decreased by 27.08% to 1.24B. Net assets increased by 5.30% to 10.42B and EPS decreased from 2.60 to N/A.
RPRX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
70.99%
Operating Margin
41.95%
Return On Investment
11.46%
12/21
03/22
06/22
09/22
Total Revenue
576M
562M
535.96M
573.46M
Gross Profit
N/A
N/A
535.96M
N/A
Operating Income
153M
218M
377.79M
192.21M
Net Income
54M
128M
491.6M
220.41M